ALS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.797200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.340200E-01
Normal-vs-Stage2
9.604600E-01
Normal-vs-Stage3
3.909200E-01
Normal-vs-Stage4
3.575200E-01
Stage1-vs-Stage2
6.114800E-01
Stage1-vs-Stage3
1.255590E-01
Stage1-vs-Stage4
5.430600E-01
Stage2-vs-Stage3
2.895600E-01
Stage2-vs-Stage4
3.512000E-01
Stage3-vs-Stage4
6.997800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.470000E-01
Normal-vs-AfricanAmerican
8.193400E-01
Normal-vs-Asian
7.803000E-01
Caucasian-vs-AfricanAmerican
7.171800E-01
Caucasian-vs-Asian
5.356600E-01
AfricanAmerican-vs-Asian
9.159800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.472600E-01
Normal-vs-Female
9.889400E-01
Male-vs-Female
7.571600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.559600E-01
Normal-vs-Age(41-60Yrs)
6.562600E-01
Normal-vs-Age(61-80Yrs)
8.907800E-01
Normal-vs-Age(81-100Yrs)
4.698400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.686800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.872200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.023350E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.148200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.893600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.845200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.850000E-01
Normal-vs-Daily Drinker
4.811400E-01
Normal-vs-Weekly Drinker
7.627800E-01
Normal-vs-Occasional Drinker
5.302400E-01
Normal-vs-Social Drinker
9.121400E-01
Non Drinker-vs-Daily Drinker
3.417000E-01
Non Drinker-vs-Weekly Drinker
3.550000E-01
Non Drinker-vs-Occasional Drinker
1.808180E-01
Non Drinker-vs-Social Drinker
8.907200E-01
Daily Drinker-vs-Weekly Drinker
1.682960E-01
Daily Drinker-vs-Occasional Drinker
1.285560E-02
Daily Drinker-vs-Social Drinker
2.476000E-01
Weekly Drinker-vs-Occasional Drinker
9.688200E-01
Weekly Drinker-vs-Social Drinker
4.664400E-01
Occasional Drinker-vs-Social Drinker
1.834590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.572200E-02
Normal-vs-Grade 2
1.275980E-02
Normal-vs-Grade 3
2.033900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.782500E-02
Grade 1-vs-Grade 3
2.723900E-02
Grade 1-vs-Grade 4
2.572200E-02
Grade 2-vs-Grade 3
3.555800E-01
Grade 2-vs-Grade 4
1.275980E-02
Grade 3-vs-Grade 4
2.033900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.688000E-01
Normal-vs-NonDiabetic
9.522600E-01
Diabetic-vs-NonDiabetic
2.564000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.373200E-01
Normal-vs-NoPancreatitis
9.985400E-01
Pancreatitis-vs-NoPancreatitis
6.437400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.415200E-01
Normal-vs-N1
9.348400E-01
N0-vs-N1
3.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.539600E-01
Normal-vs-TP53-NonMutant
9.034400E-01
TP53-Mutant-vs-TP53-NonMutant
1.451170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
